Login / Signup

A novel food-based negative oral contrast agent compared with two conventional oral contrast agents in abdominal CT: a three-arm parallel blinded randomised controlled single-centre trial.

Peter LeanderGeorgios StathisLucia Casal-DujatKarolina BomanIngvar AdnerhillJan MarsalOlof BöökThomas Fork
Published in: European radiology experimental (2022)
EudraCT (2017-002368-42) and in ClinicalTrials.gov (NCT03326518).
Keyphrases
  • study protocol
  • contrast enhanced
  • magnetic resonance
  • computed tomography
  • clinical trial
  • randomized controlled trial
  • phase iii
  • image quality
  • phase ii
  • open label
  • placebo controlled